LifeMD (NASDAQ:LFMD) (NASDAQ: LFMD) is a telehealth company headquartered in Boca Raton, Florida, offering a digital platform for primary care and specialist consultations. Founded in 2016, the company went public in 2021 through a merger with a special purpose acquisition company. LifeMD’s platform connects patients to U.S.-licensed clinicians through video visits, secure messaging and tailored care plans, with a focus on improving access to healthcare across the country.
The company’s core services center on men’s health, including treatment for erectile dysfunction, hair loss, hormone replacement therapy and weight management. In addition, LifeMD provides primary care services—such as preventive screenings, chronic condition management and lab testing—delivered via at-home sample kits or through partner laboratories. Mental health support is also available through counseling and psychiatric evaluations, reflecting the company’s broader vision of integrating physical and behavioral health.
LifeMD has grown both organically and through strategic acquisitions, enhancing its clinical offerings and pharmacy capabilities. The company maintains partnerships with nationwide compounding pharmacies and diagnostic laboratories to facilitate fast prescription fulfillment and streamline lab work. Its technology infrastructure is designed to support personalized treatment plans and ongoing patient engagement, driving adherence and improving health outcomes.
Led by CEO Phil Bane, a veteran of the digital health sector, LifeMD’s leadership team includes seasoned executives in medical, technology and regulatory affairs. The company serves patients in all 50 states, leveraging a scalable telehealth model to address the evolving needs of a modern patient population. By combining clinical expertise with digital innovation, LifeMD aims to deliver convenient, cost‐effective and high-quality care to individuals seeking personalized health solutions.
